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ABSTRACT
Background.Massively parallel sequencing technology is being used to sequence highly
diverse populations of DNA such as that derived from heterogeneous cell mixtures
containing both wild-type and disease-related states. At the core of such molecule
tagging techniques is the tagging and identification of sequence reads derived from
individual inputDNAmolecules, whichmust be first computationally disambiguated to
generate read groups sharing common sequence tags, with each read group representing
a single input DNA molecule. This disambiguation typically generates huge numbers
of reads groups, each of which requires additional variant detection analysis steps to be
run specific to each read group, thus representing a significant computational challenge.
While sequencing technologies for producing these data are approaching maturity, the
lack of available computational tools for analysing such heterogeneous sequence data
represents an obstacle to the widespread adoption of this technology.
Results.Using synthetic data we successfully detect unique variants at dilution levels of
1 in a 1,000,000 molecules, and find DeeepSNVMiner obtains significantly lower false
positive and false negative rates compared to popular variant callers GATK, SAMTools,
FreeBayes and LoFreq, particularly as the variant concentration levels decrease. In
a dilution series with genomic DNA from two cells lines, we find DeepSNVMiner
identifies a known somatic variant when present at concentrations of only 1 in 1,000
molecules in the input material, the lowest concentration amongst all variant callers
tested.
Conclusions. Here we present DeepSNVMiner; a tool to disambiguate tagged se-
quence groups and robustly identify sequence variants specific to subsets of starting
DNA molecules that may indicate the presence of a disease. DeepSNVMiner is an
automated workflow of custom sequence analysis utilities and open source tools
able to differentiate somatic DNA variants from artefactual sequence variants that
likely arose during DNA amplification. The workflow remains flexible such that it
may be customised to variants of the data production protocol used, and supports
reproducible analysis through detailed logging and reporting of results. DeepSNVMiner
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INTRODUCTION
Deep sequencing of a restricted set of gene targets in a large population of cells has
rapidly become a key application of second-generation sequencing, allowing a census of
variation to be conducted on an in vivo biological system (Fu et al., 2011; Hiatt et al., 2013;
Jabara et al., 2011; Kinde et al., 2011; Kivioja et al., 2012; Schmitt et al., 2012). Applications
of this technology allow polling of sequence variation in cancer subtypes (Forshew et al.,
2012), ascertainment of minimal residual disease (Bidard, Weigelt & Reis-Filho, 2013),
ascertainment of malignancies or antibody specificity in the immune system (Georgiou
et al., 2014) and observation of the emergence of drug resistant virus point-mutants
(Al-Mawsawi et al., 2014).
The central technique in molecule tagging that allows disambiguation of these deep
sequence datasets is the attachment of a random unique sequence identifier (UID) to
the end(s) of input DNA, either prior to or simultaneously with amplification of target
sequences (Fig. 1). Hence, even though subsequent polymerase amplification of target
sequences may introduce errors, mapping these sequences to their UID sequence allows
easy differentiation of sequence variation that was originally present in the input DNA
from variation that has been introduced during subsequent amplification steps. Recently
developed methods for molecule tagging rely on digital PCR, a process where individual
DNA molecules are assessed individually (Vogelstein & Kinzler, 1999). Several variants of
this technique have now been described (Dressman et al., 2003; Ottesen et al., 2006) with
the common thread being the binding of oligonucleotide to each individual input DNA
molecule prior to or during amplification. This technique is not to be confused with
sample barcoding or multiplexing, a process where individual samples are tagged with
small oligonucleotides and pooled in a single lane for sequencing.
In comparison to traditional massively parallel sequencing, molecule tagging has an
additional step where a small unique oligonucleotide is attached to each DNA molecule
prior to polymerase chain reaction (PCR) amplification. While both techniques generate
huge numbers of sequenced DNA molecules in parallel a potential issue with traditional
sequencing is that the introduction of erroneous base calls into a single DNA molecule
can result in inaccurate sequence information being amplified in subsequent PCR steps.
Such issues are not necessary prohibitive for reliable variant detection when samples are
relatively homogeneous however, mainly due to the relatively low base error and PCR
bias rates (Ross et al., 2013; Schirmer et al., 2015), and the ability to remove candidate PCR
duplicates reads using tools such as SAMTools (Li et al., 2009 ) or SAMBLASTER (Faust
& Hall, 2014). When the samples being sequenced are heterogeneous however, traditional
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Figure 1 DeepSNVMiner barcode and adaptor processing. A sample sequence read which has
undergone molecule tagging with a ten base pair UID consisting of five bases each attached to the
5′ and 3′ end. DeepSNVMiner first removes any adapters followed by the removal of the unique sequence
identifier (UID) from the raw sequence data. The UID sequence information is preserved in the FASTQ
header allowing for variant detection on read groups sharing a common UID.
variant detection methods often fail to reliably detect rare variants due to the small fraction
of the original material containing the variant of interest and differences in the variant
detection algorithms (Field et al., 2015). With molecule tagging techniques, we are able to
overcome PCR issues and detect rare variants within heterogeneous samples due to the
attachment of UIDs, effectively allowing the differentiation of amplification error from
variation present in the original DNA molecules (Kinde et al., 2011).
While the utility of sequencing tagged samples is clear, the analysis of sequence data
generated with UID tags is non-trivial and, as yet, software or a computational workflow
does not exist in the public domain to allow easy calling and tallying of this mutation
information. The fundamental technical challenge of working with such data is largely due
to the wide variety of methods for attaching UIDs, methods that generate vastly different
UIDs with regard to total sequence length and their position on themolecules relative to the
sequence of interest and/or adaptors. The ability to work with such data requires software
where users can first define the nature of the specific UID in their experiment, followed by
an analysis workflow where UIDs are temporarily removed from raw sequence data for the
alignment step and later restored as a means of grouping the individual reads by common
UID. Finally, variants must be called within each group of input molecules sharing a
common UID, a computationally intensive task given the huge numbers of groups often
generated in a single experiment. To address this need we present DeepSNVMiner, a tool
able to detect rare single nucleotide variants and small indels specific to a single amplified
DNA molecule identified by a unique tagged sequence identifier. The DeepSNVMiner
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workflow consists of grouping reads by UID tag sequences and calling variant bases in
UID groups, thus identifying mutations that existed in single molecules from the original
heterogeneous input DNA. DeepSNVMiner is a standalone-automated workflow that runs
in a Linux or Macintosh environment and has been successfully used even on modest
desktop hardware.
MATERIALS & METHODS
Cell lines used
Two cell lines were utilised in the dilution series experiment, HEK293 and OCI-LY10.
HEK293 is available from ATCC (accession CRL-1573; http://www.atcc.org/products/all/
CRL-1573.aspx) and OCI-LY10 from Ontario Cancer Institute (accession CVCL_8795;
https://www.abmgood.com/OCI-Ly10-Cell-Lysate-Data-Sheet-L134.html).
Software input
Running DeepSNVMiner requires three input files; paired-end FASTQ read files and
a BED file containing the specific locations of targeted genomic region(s). An initial
configuration step is also required to determine the location of three required external
resources; Burrows-Wheeler Aligner (BWA) (Li & Durbin, 2009), SAMtools (Li et al.,
2009), and a reference genome FASTA file with BWA index files.
Workflow design
The workflow to disambiguate sequence variants from their unique sequence ID tags
groups involves multiple steps involving both purpose built tools and calls to external
binaries (Fig. 2).
First, the sequence read dataset is subjected to preliminary quality control, to remove
low quality reads or those containing predominantly N calls (and hence avoid assigning
UID groups of consecutive N’s). The data is next interrogated for the presence of obvious
adaptor sequence, which may contaminate UID tags if left untrimmed. Each UID tag is
then identified based on the user defined input and removed from the FASTQ sequence
line and appended to the existing FASTQ read header. These filtered reads and headers are
written to new FASTQ files with the UID header information later used to detect variants
specific to common UID groups. DeepSNVMiner is flexible with regard to the structure
of the UID tag as both the expected UID length and strand location of the UID typically
vary depending on the tagging protocol and/or sequencing technology used. For example,
frequently the UID is appended solely at the 5′ end of the amplified region, but in other
protocols the sequence from both the 5′ and the 3′ ends needs to be concatenated to derive
theUID.Next, themodified reads are aligned to a reference genome sequence with BWA (Li
& Durbin, 2009) using a set of alignment parameters that are permissive of mismatches but
which penalise opening a gap within the alignment, especially at the ends of sequence reads.
Variant bases are then identified base-by-base using the SAMTools calmd command (Li
et al., 2009) within a predefined set of user-specified target genomic locations input from a
BED-format file. SAMtools calmd is used instead of the more standard SAMtools/BCFtools
workflow, as running themillions of commonUID groups we typically observe through the
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Figure 2 DeepSNVMiner workflow.DeepSNVMiner Workflow consists of seven major steps: UID
definition, sequence data QC, UID processing and grouping, alignment, variant detection, report
generation, and optionally graphing.
entire SAMtools/BCFtools workflow is computationally prohibitive. Output from calmd is
next parsed and variant positions and the reads in which they occur are tallied and grouped
according to read UIDs. By default, common UID groups of 5 or more reads of which at
least 40% detect the same variant are classified as a variant ‘super mutant’ and variants
reported in two or more super mutants further classified as a ‘super group.’ This default
value of 40% was chosen to allow successful super mutant detection even in the rare cases
where a super mutant was missed due to an identical UID tag being added to two distinct
DNAmolecules. Examination of pilot data determined lowering this threshold did not add
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any false positive super mutants and further, users of the software are able to override the
defaults and determine the appropriate value for each cut-off based on the nature of their
dataset and the method by which it was generated. Finally, optional summary graphics of
the variants in the context of sequence read depth and chromosomal position are created
using R.
Workflow implementation
The overall workflow is comprised of discrete command-line interface calls to both
custom- and open source-tools as well as UNIX utilities. All commands are stored within
a configuration module and executed by a Perl wrapper script to allow chaining together
of each command and automation of the multifaceted workflow. This also allows for easy,
frequent customisation of workflow commands (should this be desired) and the capturing
of specific commands and run-level information into a log file that contributes to analysis
reproducibility. The workflow has the facility to allow it to be resumed or re-run from any
point midway through the analysis.
The workflow commands, specifically, are various calls to several purpose-built tools
(implemented in Perl), external open-source bioinformatics software tools and UNIX
utilities. Custom Perl scripts are used to perform workflow steps to identify, remove and
store UID tags from each read, to aggregate and summarise variant calls within UID groups
and to generate final reports and graphs. Alignment of sequence reads is accomplished
using BWA, variant calling is done with SAMtools calmd, and graphing performed with R.
Identification and cleaning of reads containing runs of Ns is performed using sed and awk
commands piped to other UNIX utilities such as cut, sort, uniq, and cat which are required
to manipulate the output of these tools.
Output
The final report contains a listing of all variants detected, based on either the user-configured
expected variant frequency or default parameters (e.g., a commonUID groupmust contain
at least five reads with at least 40% sharing the same variant). For each called variant, the
output super mutant summary reports the chromosome and genomic coordinate(s), the
variant base, the UID, the number of total variant reads in the groups, the number of reads
in the group and the fraction of variant reads. The super group report contains information
on recurrent super mutants (grouped by common genomic coordination and variant base)
and additionally reports their frequency.
RESULTS AND DISCUSSION
We developed DeepSNVMiner to disambiguate tagged sequence groups within mixed cell
populations and detect sequence variants specific to individual amplified DNA molecules.
To assess the performance of DeepSNVMiner we first compare it to the well known variant
callers FreeBayes, (http://arxiv.org/abs/1207.3907), Genome analysis toolkit (GATK)
(McKenna et al., 2010), SAMTools/BCFtools (Li, 2011), and LoFreq (Wilm et al., 2012)
using simulated tagged sequence data at increasing variant dilution levels. Next, we test
DeepSNVMiner by running a dilution series with genomic DNA from two cells lines: one
of which is known to contain a known heterozygous somatic variant.
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Figure 3 Variant caller false positive rate at increased dilution levels. False positive rates for Deep-
SNVMiner compared to FreeBayes, GATK, LoFreq, and SAMTools at increasing variant dilution levels us-
ing synthetic data.
Comparison with existing software
To test the effectiveness of DeepSNVMiner at increasing dilution levels two datasets
containing 100-bp paired-end reads from chromosome 22 of the human reference genome
(GRCh37) were created, with each read-pair having a randomly generated 10 bp barcodes
attached at the 5′ end to simulate the attachment of a UID sequence tag to the original
DNAmolecule. The first input data set contained nomutations while the second input data
set contained randomly generated single nucleotide variants (SNVs) with each mutated
read duplicated randomly between 1 to 50 times within the FASTQ files to simulate the
polymerase chain reaction (PCR) replication process of initial DNA fragments. Mixing the
two data sets in appropriate concentrations simulated dilution levels of 0%, 50%, 90%,
99%, 99.9%, 99.99%, 99.999%, and 99.9999%with 4,000,000 million total paired end reads
ultimately added to each FASTQ file. For each dilution level the FASTQ files were first
aligned to chromosome 22 and variants called using DeepSNVMiner, FreeBayes, GATK,
SAMTools, and LoFreq run with default parameters or as suggested in documentation
(Table S1). False positive (Fig. 3) and false negative rates (Fig. 4) were then calculated
(Table S2).
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Figure 4 Variant caller false negative rate at increased dilution levels. False negative rates for
DeepSNVMiner compared to FreeBayes, GATK, LoFreq, and SAMTools at increasing variant dilution
levels using synthetic data.
Table 1 Variant caller ability to detect known heterozygous mutation at different dilution levels. A
dilution series was performed with genomic DNA from two cells lines: HEK293 containing wild-type
MYD88 and OCI-LY10 containing known heterozygous L265P MYD88 mutation. The ability to detect
the known heterozygous mutation was determined for DeepSNVMiner, FreeBayes, GATK, LoFreq, and
SAMTools at increasing dilution levels.
Dilution Percent Deep- SNVMiner FreeBayes GATK LoFreq SAMTools
0 Detected Detected Detected Detected Detected
90 Detected Not detected Detected Detected Not detected
99 Detected Not detected Not detected Detected Not detected
99.9 Detected Not detected Not detected Not detected Not detected
99.99 Not detected Not detected Not detected Not detected Not detected
99.999 Not detected Not detected Not detected Not detected Not detected
99.9999 Not detected Not detected Not detected Not detected Not detected
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Figure 5 DeepSNVMiner dilution series results. To measure the sensitivity of DeepSNVMiner a
dilution series containing known heterozygous L265P MYD88 mutation was performed. DeepSNVMiner
was able to detect the mutation in a sample where only 1 in 1,000 samples contained the mutation.
Real data evaluation
To evaluate the performance of DeepSNVMiner on real data versus other variant callers, we
performed a dilution series using a mixture of genomic DNA from two cell lines HEK293
andOCI-LY10 (Table S3). Cell line OCI-LY10 carries a heterozygous pointmutation within
the MYD88 gene at L265P or chr3:38172641 (GRCh37), a somatic mutation occurring
frequently in non-Hodgkin lymphoma (Ngo et al., 2011). It would be clinically useful to
have a method to detect and enumerate rare cells carrying this mutation in samples of
blood or bone marrow. For each cell mixture in the dilution series, a 116 bp genomic
region surrounding chr3:38172641 was amplified using primers with UID tags and sample
ID tags and a per-sample average of 183 thousand paired-end reads were sequenced on
an Illumina MiSeq. The resulting sequence reads were analysed with DeepSNVMiner,
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FreeBayes, GATK, LoFreq, and SAMTools and the ability to detect the heterozygous
mutation was measured.
DeepSNVMiner was successfully able to detect the mutation in dilution levels down to
1/1000 compared to 1/100 for LoFreq, 1/10 for GATK, and only in the non-diluted sample
for FreeBayes and SAMTools (Table 1). In the non-diluted sample, DeepSNVMiner was
able to detect the mutation in 4,055 separate super mutants consisting of 59,038 total
DNA sequences and at the lower range of detection (1/1000), DeepSNVMiner detected the
variant in 6 separate super mutants consisting of 120 total DNA sequences (Fig. 5)
The mutation was reliably detected at concentrations of 1/1000 by DeepSNVMiner
but not in concentrations of 1/10000 indicating the lower detection limit lies somewhere
in this range. However, it should be noted this limit is imposed by current laboratory
methodology however, as DeepSNVMiner remains capable of achieving the theoretical
limits of the technology imposed by the chosen length of UID sequences.
CONCLUSIONS
Wepresent DeepSNVMiner; an integrated tool set and automated workflow to allow robust
and reliable identification of sequence variants present in a subset of sequences within a
tagged input DNA sample. This tool makes available the analysis procedure required to
support SafeSeqs and similar UID tagged sequence datasets. DeepSNVMiner has been built
to allow easy automation and reproducibility and makes this technique available to a wide
range of applications.
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